Quality of Life After Starting Highly Active Antiretroviral Therapy for Chronic HIV-1 Infection at Different CD4 Cell Counts
Authors:
- Pythia T NieuwkerkPNPythia T Nieuwkerk
- Milly E Hillebrand-HaverkortMHMilly E Hillebrand-Haverkort
- Robert VriesendorpRVRobert Vriesendorp
- Ph Jos FrissenPFPh Jos Frissen
- Frank de WolfFWFrank de Wolf
- Mirjam Ag SprangersMSMirjam Ag Sprangers
- 15 August 2007
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 45 (5) , 600-601
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Patients’ Preferences regarding the Timing of Highly Active Antiretroviral Therapy Initiation for Chronic Asymptomatic HIV-1 InfectionAntiviral Therapy, 2006
- Mortality and progression to AIDS after starting highly active antiretroviral therapyAIDS, 2003
- Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell StrataAnnals of Internal Medicine, 2003
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesThe Lancet, 2002
- Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 × 106/lAIDS, 2002
- Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug TherapyJAMA, 2001
- A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV diseaseAIDS, 1998
- Reliability and Validity of Physical and Mental Health Summary Scores from the Medical Outcomes Study HIV Health SurveyMedical Care, 1998
- Disease-Related Factors Associated With Health-Related Quality of Life in People With Nonadvanced HIV Disease Assessed Using an Italian Version of the MOS-HIV Health SurveyJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- A Health Status Questionnaire Using 30 Items From The Medical Outcomes StudyMedical Care, 1991